These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38890285)

  • 1. The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.
    Pathania AS; Chava H; Chaturvedi NK; Chava S; Byrareddy SN; Coulter DW; Challagundla KB
    Cell Death Dis; 2024 Jun; 15(6):428. PubMed ID: 38890285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer.
    Deng M; Wu D; Zhang Y; Jin Z; Miao J
    Gynecol Oncol; 2021 Jul; 162(1):190-199. PubMed ID: 33875234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation.
    Xiang T; Li Y; Liu G; Li X
    J Cell Mol Med; 2024 May; 28(10):e18360. PubMed ID: 38785199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
    Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
    Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
    Nygren MK; Tekle C; Ingebrigtsen VA; Mäkelä R; Krohn M; Aure MR; Nunes-Xavier CE; Perälä M; Tramm T; Alsner J; Overgaard J; Nesland JM; Borgen E; Børresen-Dale AL; Fodstad Ø; Sahlberg KK; Leivonen SK
    Br J Cancer; 2014 Apr; 110(8):2072-80. PubMed ID: 24577056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity.
    Lee CC; Ho KH; Huang TW; Shih CM; Hsu SY; Liu AJ; Chen KC
    Life Sci; 2021 Jul; 277():119438. PubMed ID: 33798549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
    Hu X; Xu M; Hu Y; Li N; Zhou L
    Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7-H3 in head and neck squamous-cell carcinoma.
    Li H; Yang Z; Yang X; Zhang F; Wang J; Wu Z; Wanyan C; Meng Q; Gao W; Yang X; Wei J
    Cell Death Dis; 2022 Feb; 13(2):109. PubMed ID: 35115487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
    Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.
    Brignole C; Calarco E; Bensa V; Giusto E; Perri P; Ciampi E; Corrias MV; Astigiano S; Cilli M; Loo D; Bonvini E; Pastorino F; Ponzoni M
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
    Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.
    Neviani P; Wise PM; Murtadha M; Liu CW; Wu CH; Jong AY; Seeger RC; Fabbri M
    Cancer Res; 2019 Mar; 79(6):1151-1164. PubMed ID: 30541743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
    Meng F; Yang M; Chen Y; Chen W; Wang W
    Cancer Immunol Immunother; 2021 Aug; 70(8):2247-2259. PubMed ID: 33492448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of miR-29c/B7-H3 axis in children with allergic asthma.
    Zhang X; Zhao X; Sun H; Yan Y; Huang L; Gu W; Jiang W; Wang Y; Zhu C; Ji W; Hao C; Chen Z
    J Transl Med; 2018 Aug; 16(1):218. PubMed ID: 30075787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
    Xu H; Cheung IY; Guo HF; Cheung NK
    Cancer Res; 2009 Aug; 69(15):6275-81. PubMed ID: 19584290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
    Lee YH; Martin-Orozco N; Zheng P; Li J; Zhang P; Tan H; Park HJ; Jeong M; Chang SH; Kim BS; Xiong W; Zang W; Guo L; Liu Y; Dong ZJ; Overwijk WW; Hwu P; Yi Q; Kwak L; Yang Z; Mak TW; Li W; Radvanyi LG; Ni L; Liu D; Dong C
    Cell Res; 2017 Aug; 27(8):1034-1045. PubMed ID: 28685773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of miR-29c/B7-H3/Th17 axis in children with Mycoplasma pneumoniae pneumonia.
    Li QL; Wu YY; Sun HM; Gu WJ; Zhang XX; Wang MJ; Yan YD; Hao CL; Ji W; Chen ZR
    Ital J Pediatr; 2019 May; 45(1):61. PubMed ID: 31088519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.